The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and ...

The biodegradable polymer Poly (D,L-lactide-co-glycolic acid) (PLGA) is widely regarded as safe for use in medical applications, seeing common use in the creation of particles used in in vivo studies.

Adipo Therapeutics LLC , a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related ...

The facility showcases production capacities of 100 tonne per annum (TPA) for Lactic Acid; and 60 TPA for Lactide, equivalent to 55 TPA for PLA. Commenting on the landmark development, Pramod ...

Mucus presents a formidable barrier to nanoparticle drug-delivery systems, but adding a coating of polymer molecules helps them sneak through the net. Mucus, the amorphous, sticky substance that ...

Nanomedicine. 2012;7(8):1225-1233. Most of the strategies described for the passage of drugs across the BBB can be enhanced by nanotechnology and some of the mechanisms involved include: NPs open ...

The new facility spans three acres and has production capacities of 100 tonnes per annum for Lactic Acid, 60 tonnes for lactide, and 55 tonnes for PLA. It includes fermentation, chemical synthesis ...

Advances in the functionality of multifunctional nanoparticles push their potential for the remote detection and treatment of cancer nearer to real-life patient care. The growth of biomaterial ...

It showcases the capacity to produce 100 tons per annum (TPA) of lactic acid, 60 TPA of lactide, and 55 TPA of PLA. This facility marks a significant step in scaling up bio-based plastics in India.